THE latest issue of the NPS
Radar has been released online,
containing independent, evidencebased
assessments of new drugs
and new PBS listings.
This month’s issue covers two of
the new class of dipeptidyl
peptidase-4 (DPP-4) inhibitors
sitagliptin (Januvia) and vildagliptin
(Galvus), as well as the new
autoinjector Anapen and reviews
and info on Panadol Extra,
Colchicine for acute gout,
pramipexole (Sifrol ER), Anakinra
(Kineret) and Exenatide (Byetta).
See www.nps.org.au/radar.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Aug 10
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.